Futures and Commodity Market News
Vaccine Adjuvants Global Market 2019 | Industry Insights, Size Estimation, Growth Analysis, Development Trends, Business Opportunities, Top Company Players, Forecast to 2023Jun 06, 2019 (Heraldkeeper via COMTEX) — Vaccine Adjuvants Market Research Report Outlook 2019 to 2023. Vaccine Adjuvants Market Size Analysis By Type (Pathogen Components, Particulate Adjuvants, others), Route of Administration (Oral, Intramuscular, Subcutaneous, and Intradermal), and End Users (Pediatric, Adult) – Global Forecast Till 2023 Global Vaccine Adjuvants Market Overview A vaccine adjuvant is an immunological agent which aids in the modification of the effect of other agents. A vaccine adjuvant is added to a vaccine to enhance the immune response and enable long-lasting protection against antigens. Many products, chemicals like aluminum phosphate, aluminum hydroxide, and aluminum potassium sulfate are used as adjuvants in the production of vaccines. The current report by Market Research Future (MRFR) claims that the global vaccine adjuvant market is expected to mushroom at 10.1% CAGR during the forecast period of 2017-2023. Various factors snowballing growth in the global vaccine adjuvants market include the increasing demand for adjuvants for enhancement and extension of immune response and need for the development of non-toxic adjuvants. Furthermore, hefty investments by companies in the research and development, magnifying focus on immunization programs, and the intensifying demand for vaccines are anticipated to promote market growth for vaccine adjuvants. Also, increasing prevalence of diseases in children and a rising number of awareness programs to promote vaccination are estimated to augment market to a great extent. Even though many factors are causative of the positive ascension of the market, the high toxicity of adjuvants and a high cost of developing new vaccine adjuvants are likely to act as market restraints during the forecast period. Request Free Sample @ https://www.marketresearchfuture.com/sample_request/1098 Market Segmentation The global vaccine adjuvants market is segmented by types, routes of administration, end-users, and region. Based on types, the global vaccine adjuvants market is segmented into particulate adjuvants and pathogen components. Based on routes of administration, the global vaccine adjuvants market is analyzed for the segments of intramuscular, oral, intradermal, and subcutaneous. Based on end-users, the market is segmented into pediatric, adult. Detailed Regional Analysis The global vaccine adjuvants market is segmented, based on region, into the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas are further segmented into North America and Latin America. Europe is further segmented into Western Europe and Eastern Europe. Asia Pacific is studied for country-specific markets of China, India, Japan, Australia, Republic of Korea, and Rest of Asia Pacific. Among the primary regional segments, the Americas are estimated to spearhead the global vaccine adjuvants market. This can be owed to the significant initiatives launched by the government for vaccination against many diseases, coupled with the excellent management of public awareness programs. Europe is likely to follow the Americas and garner the second largest market for vaccine adjuvants. Such upscaling of the market in the region can be attributed to the increasing emphasis on the research and development of new and enhanced vaccine adjuvants. Further, substantial funds invested in the same are promoting positive ascension of the vaccine adjuvants market. Also, the governments in the region are observed to campaign about the advantages of vaccination and numerous preventive measures against infectious and non-infectious diseases, driving the market exponentially. Asia Pacific is expected to expand at a relatively higher rate during the forecast period. Governments in several developing economies residing in Asia Pacific have undertaken a significant number of vaccination programs to educate people and create necessary awareness. Within Asia Pacific, India is estimated to emerge as the fastest growing market for vaccine adjuvants. This fast-paced upscaling can be attributed to the rapid population growth in the country and the increasing focus on immunization programs by the government in collaboration with various NGOs. The market for vaccine adjuvants in the Middle East and Africa is expected to showcase a steady growth through the assessment period. This can be owed to the lower demand for vaccine adjuvants in comparison to other regions across the globe. Key Players Some of the significant market vendors for vaccine adjuvants include VaxLiant LLC.(U.S), Aphios Corporation (U.S), Vaxine Pty Ltd (Australia), Agenus, Inc. (U.S),Viscogel AB (Sweden), Sergeant Adjuvants (U.S), Adjuvatis (France), Brenntag Biosector (Denmark), CureVac AG (Germany), Sigma-Aldrich Co. LLC.(India), SPI Pharma, Inc.(U.S), Avanti Polar Lipids, Inc. (U.S), SEPPIC (Fracne), Novavax, Inc.(U.S), MPV Technologies (U.S), Invivogen (U.S), CSL Limited (Australia), and OZ Biosciences (France). Ask Questions To The Experts @ https://www.marketresearchfuture.com/enquiry/1098 Industry Update May 2019: Biomedical Advanced Research and Development Authority (BARDA) has informed Emergent BioSolutions Inc. will start the procurement of AV7909 (anthrax vaccine adsorbed with CPG 7909 vaccine adjuvant) to provide delivery into the Strategic National Stockpile, according to the announcement made by Emergent BioSolutions Inc. Table Of Contents 1 Report Prologue 2 Market Introduction 2.1 Introduction 2.2 Scope Of Study 2.3 Research Objective 2.4 Assumptions & Limitations 2.4.1 Assumptions 2.4.2 Limitations 3 Research Methodology 3.1 Research Process 3.2 Primary Research 3.3 Secondary Research 4 Market Dynamics 4.1 Drivers 4.2 Restraints 5 Market Factor Analysis 5.1 Porter's Five Forces Model 5.1.1 Bargaining Power Of Suppliers 5.1.2 Bargaining Power Of Buyers 5.1.3 Threat Of New Entrants 5.1.4 Threat Of Substitutes 5.1.5 Intensity Of Rivalry Browse Complete Report with TOC at: https://www.marketresearchfuture.com/reports/vaccine-adjuvants-market-1098 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact: Akash Anand Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com Please read the End User Agreement. News provided by COMTEX. |
|
Jun
06